UBE2N and acute myeloid leukemia: To determine whether UBE2N activity is preferentially required in AML cells with elevated immunoproteasome expression, we examined the correlation between UBE2Ni sensitivity and the expression of immunoproteasome subunit genes (Figure 5G and Supplemental Table 7).